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Abstract 
The importance of the working document is that it allows analyzing the information and status of the  
cases associated with (SARS-CoV-2) COVID-19  as open data at the municipal, state and national levels, 
with a daily registry of patients, according to age, sex, comorbidities, for the condition of (SARS-CoV-2) 
COVID-19 according to the following characteristics: a) Positive, b) Negatives, c) Suspects. Likewise, it 
presents information regarding the identification of an outpatient and / or hospitalized patient, attending 
to their medical development, identifying: a) Recovered, b) Deaths and c) Assets, in Phase 3 and Phase 4, 
at the national state and municipal level in Mexico, the data analysis is carried out by applying an algorithm 
of data mining, which provides the information, fast and timely, required for the estimation of Scenarios 
for Medical Care of the (SARS-CoV-2) COVID-19. 
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Specifications Table  
Subject Infectious Diseases 
Specific subject area Information from the Viral Respiratory Diseases Epidemiological 
Surveillance System for (SARS-CoV-2) COVID-19 in Mexico 
Type of data Table 
Figure 
How data were acquired Government of Mexico. Health Secretary. Databases Covid-19 México  
https://datos.gob.mx/busca/dataset/informacion-referente-a-casos-
covid-19-en-mexico/resource/e8c7079c-dc2a-4b6e-8035-08042ed37165 
Instruments:  
Software Orange Data Mining version 3.25.1 https://orange.biolab.si 
Make and model and of the instruments used: 
Algorithm for the identification of patients according to following 
characteristics: a) Positive, b) Negatives, c) Suspects. Likewise, it presents 
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information regarding the identification of an outpatient and / or 
hospitalized patient, attending to their medical development, identifying: 
a) Recovered, b) Deaths and c) Assets 
Data format The information is presented in raw in CVS format, the Ministry of Health 
of Mexico since April 14, 2020 published the cases associated with (SARS-
CoV-2) COVID-19 as open data. The data processing corresponds to the 
records on the epidemic (SARS-CoV-2) COVID-19 at 1 June 2020. The 
treatment of the information is carried out through the application 
software for data mining Orange version 3.25.1, in which the algorithm for 
the analysis of information is filtered to present the current scenario in 
Mexico of the SARS-CoV-2 (COVID 19). 
Parameters for data 
collection 
The information is presented at the municipal, state and national levels, 
with a daily registry of patients, according to age, sex, comorbidities, for 
the condition of (SARS-CoV-2) COVID-19 according to the following 
characteristics: a) Positive, b) Negatives, c) Suspects. Likewise, it presents 
information regarding the identification of an outpatient and / or 
hospitalized patient, attending to their medical development, identifying: 
a) Recovered, b) Deaths and c) Assets. 
Description of data 
collection 
This information is filtered to present the current scenario in Mexico of 
the SARS-CoV-2 (COVID 19) in a fast and timely manner, to support public 
decision-making in health matters. 
Data source location Institution: Universidad Veracruzana / Instituto de Investigaciones y 
Estudios Superiores Económicos y Sociales 
Country: México 
Data accessibility Raw data can be retrieved from the Github repository 
https://github.com/CMedelR/dataCovid19/edit/master/README.md 
 
 
Value of the Data 
• The Algorithm for the identification of patients (SARS-CoV-2) COVID 19 in Mexico allows to analyze 
at the municipal, state and national level, the registry of patients, according to age, sex, 
comorbidities, for condition of (SARS-CoV-2) COVID-19 according to the following characteristics: 
a) Positive, b) Negative, c) Suspicious, as well as presenting information on the identification of 
an outpatient and / or hospitalized patient, attending to their medical development, identifying: 
a) Recovered, b ) Deaths and c) Assets, in Phase 3 and Phase 4, in a fast and timely manner, to 
support public decision-making in health matters. 
• Taking into account their strategic roles in public health and researchers can use the data from 
this study to identify the action scenario for decision-making in the combat of (SARS-CoV-2) COVID 
19 in Phase 3 and Phase 4. 
• The importance of data analysis is that it allows identifying the cases (SARS-CoV-2) COVID-19 in 
Mexico is concentrated on a daily for patients of (SARS-CoV-2) COVID-19 and and allows preparing 
action scenarios for making public health policy decisions to combat SARS-CoV-2) COVID-19 in 
Mexico. 
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Data Description 
 
The source of information on the number of registered cases of (SARS-CoV-2) COVID-19 at 1 June 2020 
for Mexico comes from the website https://datos.gob.mx/busca/dataset/informacion-referente-a-casos-
covid-19-en-mexico/resource/e8c7079c-dc2a-4b6e-8035-08042ed37165 by the Ministry of Health, with 
the participation of the National Council for Science and Technology (CONACYT), the Center for Research 
in Geospatial Information Sciences (CENTROGEO), the National Laboratory for Geo-Intelligence (GEOINT), 
the Data Laboratory of the National Laboratory for Geointelligence (DataLab), where the registry of 
COVID-19 cases (SARS-CoV-2) COVID-19 is concentrated, and is the official means of communication and 
information on the epidemic in Mexico. 
 
The information of the cases (SARS-CoV-2) COVID-19 in Mexico is concentrated on a daily basis since April 
19, 2020, communication and official information on the epidemic in Mexico, the data are presented at 
the municipal, state and national levels, with a daily registry of patients, according to age, sex, 
comorbidities, for the condition of (SARS-CoV-2) COVID-19 according to the following characteristics: a) 
Positive, b) Negatives, c) Suspects. Likewise, it presents information regarding the identification of an 
outpatient and / or hospitalized patient, attending to their medical development, identifying: a) 
Recovered, b) Deaths and c) Assets. The data processing corresponds to the records on the epidemic 
(SARS-CoV-2) COVID-19 at May 18, 2020. The treatment of the information is carried out through the 
application software for data mining and visual programming Orange Data Mining version 3.25.1.  Orange 
Data Mining is a machine learning and data mining suite for data analysis through Python scripting and 
visual programming. [1] 
 
According to (WHO, 2020) the (SARS-CoV-2) COVID-19 disease pattern presents 4 scenarios identified 
from the confirmation of Laboratory Diagnosis: a) Not Infected or b) Infected, in this finally, the following 
categories are observed, taking into account age and specific comorbidities in each case: a) Mild Infection, 
b) Moderate Infection, c) Severe Infection and d) Critical Infection. 
 
Depending on the category observed in Patients who have a Confirmation of Infected, as in the case of a) 
or b) it can assume the character of Outpatient, so the strategy is isolation or "quarantine" at home, where 
the result It is hoped that he will recover. Regarding the Patients who have a Confirmation of Infected, in 
categories c) and d) they assume the character of Hospitalized Patient, with a probability of requiring care 
in Intensive Care Units and requiring Intubation, and where it is hoped to save as many patients as 
possible. 
 
The importance of the research is that it allows identifying the action scenario for making public health 
policy decisions to combat CO(SARS-CoV-2) COVID-19, since they consider the following states of process 
in medical treatment, in order to carry out the Estimate of Scenarios for Medical Care of the (SARS-CoV-
2) COVID-19  under the following premises of hospital care: 
1. A patient with a positive (SARS-CoV-2) COVID-19 laboratory diagnosis can be considered: a) 
Outpatient, or b) Hospitalized. 
2. If the (SARS-CoV-2) COVID-19 Positive patient is Hospitalized, the following should be considered: a) 
Enter the Intensive Care Unit or b) Do not enter the Intensive Care Unit. 
3. If the (SARS-CoV-2) COVID-19 Positive patient is Hospitalized and Entered into the Intensive Care 
Unit, the following should be considered: a) The patient requires intubation or b) The patient does 
NOT require intubation. 
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Methods 
 
The information is presented in raw in CVS format, the Ministry of Health of Mexico. The data processing 
corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 1  June 2020. The treatment of the 
information is carried out through the application software for data mining Orange version 3.25.1, in 
which the algorithm for the analysis of information are developed and it is filtered to present the current 
scenario in Mexico of the SARS-CoV-2 (COVID 19). In this way, the algorithm that is presented allows us 
to project the requirements for the use of installed infrastructure in the face of the growing requirement 
for patient care Positive (SARS-CoV-2) COVID-19, allowing the identification of scenarios at the national, 
state and municipal levels. The construction of the algorithm is based on the following definitions. 
 
Definition 1: Total Patients to consider in Model (SARS-CoV-2) COVID-19.- It is the number of total patients 
according to the confirmatory laboratory result or not of (SARS-CoV-2) COVID-19). 
Be: 
TP SARS-CoV-2 i j = Total patients according to (SARS-CoV-2) COVID-19 confirmatory laboratory result  
Which consists of: 
TP SARS-CoV-2 i j = (P + SARS-CoV-2 i j) + (P- SARS-CoV-2 i j) + (Px SARS-CoV-2 i j),  where: i = State, j = 
Municipality 
Of which: 
P+ SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Municipality 
P-  SARS-CoV-2 i j = Patient with negative (SARS-CoV-2) COVID-19 result in the State, Municipality 
Px  SARS-CoV-2 i j = Patient with pending confirmation (SARS-CoV-2) COVID-19 in the State, Municipality 
 
Definition 2: Identification of a suspected (SARS-CoV-2) COVID-19 case.- This is the patient who undergoes 
an initial qualification according to the initial diagnostic characteristics indicated in the case definitions 
for surveillance by the World Health Organization for primary care of (SARS-CoV-2) COVID-19 cases. 
Be: 
CsCOVID 19 (SARS-CoV-2) = Patient with initial classification as a suspected case of (SARS-CoV-2) COVID-
19 
Where: 
Cs (SARS-CoV-2) COVID-19 = Cs (SARS-CoV-2) COVID-19 Type 1 + Cs (SARS-CoV-2) COVID-19  Type 2 + Cs 
(SARS-CoV-2) COVID-19  Type 3 
Of which: 
According to the World Health Organization, there are 3 categories (identified as Type 1, Type 2 and Type 
3) to identify suspected cases of (SARS-CoV-2) COVID-19, defined below: 
1. Cs (SARS-CoV-2) COVID-19 Type 1.- Is a patient with acute respiratory disease (fever and at least 
one sign / symptom of respiratory disease, with no other aetiology that fully explains the clinical 
presentation and a history of travel or residence in a country / area or territory that reports local 
transmission of COVID-19 disease during the 14 days prior to the onset of symptoms. 
2. Cs (SARS-CoV-2) COVID-19 Type 2.- He is a patient with an acute respiratory disease, who has 
been in contact with a confirmed or probable COVID-19 case in the last 14 days before the onset 
of symptoms. 
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3. Cs (SARS-CoV-2) COVID-19 Type 3.- Is a patient with severe acute respiratory infection (fever and 
at least one sign / symptom of respiratory illness (eg cough, shortness of breath) and requiring 
hospitalization and without another etiology that fully explains the clinical presentation. 
 
Definition 3: Total Patients to consider in the (SARS-CoV-2) COVID-19  Model .- It is the number of total 
patients according to the confirmatory laboratory result or not of (SARS-CoV-2) COVID-19). 
Be: 
TP SARS-CoV-2 i j = Total patients according to confirmatory laboratory result or not of (SARS-CoV-2) 
COVID-19  
Which consists of: 
TP SARS-CoV-2 i j = (P + SARS-CoV-2 i j) + (P- ARS-CoV-2 i j) + (Px ARS-CoV-2 i j) , where: i = State, j = 
Municipality 
Of which: 
P + SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Municipality 
P- ARS-CoV-2 i j = Patient with negative (SARS-CoV-2) COVID-19 result in the State, Municipality 
Px ARS-CoV-2 i j = Patient with pending confirmation (SARS-CoV-2) COVID-19 in the State, Municipality 
 
Definition 4: Positive Patients for (SARS-CoV-2) COVID-19 i j.- It is the number of patients with laboratory 
results with positive confirmation for (SARS-CoV-2) COVID-19 i j . 
It has: 
P + SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Municipality 
 
Definition 5.- Medical Treatment Strategy for a patient with positive laboratory confirmation for (SARS-
CoV-2) COVID-19 i j .- It is the Action Plan in Medical Treatment for a patient with positive laboratory 
confirmation for SARS-CoV-2 in attention to your degree of infection and comorbidities present that is 
channeled to determine the Physician. 
 
According to the Strategy of Medical Care required for Patients with a Positive SARS-CoV-2 Result, 
according to their degree of identified infection, they have the following. 
Be: 
ET P + SARS-CoV-2 i j = Medical Treatment Strategy P + SARS-CoV-2 i j 
 
The medical treatment for a patient with a positive laboratory result for (SARS-CoV-2) COVID-19, based 
on the Medical Treatment Strategy (ETM P + SARS-CoV-2 ij), based on his degree of infection and present 
comorbidities, poses two action scenarios : i) Outpatient (SARS-CoV-2) COVID-19  patient or ii) 
Hospitalized (SARS-CoV-2) COVID-19  patient. 
Be: 
i) Outpatient COVID19 patient. 
      P + SARS-CoV-2 i j Outpatient = Positive (SARS-CoV-2) COVID-19 with Outpatient mode in the State, 
Municipality 
ii) COVID19 Patient Hospitalized. 
      P + SARS-CoV-2 i j Hospitalized = Positive (SARS-CoV-2) COVID-19 with modality Hospitalized in the 
State, Municipality 
where: 
Depending on the degree of infection (I1, I2 or I3), the Hospitalized (SARS-CoV-2) COVID-19  Patient may 
require: i) Access to the Intensive Care Area without Intubation or ii) Access to the Intensive Care Area 
with Intubation. 
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Definition 6.- Patients with a Positive (SARS-CoV-2) COVID-19 Result Hospitalized with Access to the 
Intensive Care area.-  It is the number of Patients with a Positive SARS-CoV-2 Result Hospitalized with 
Access to the Intensive Care area, according to its degree of infection. 
Be: 
P + SARS-CoV-2 i j Hospital Intensive Care = Positive (SARS-CoV-2) COVID-19 with modality 
Hospitalized in the State, Municipality 
 
Definition 7.- Patients with a positive (SARS-CoV-2) COVID-19 result Hospitalized with access to the 
Intensive Care Area with Intubation.-  It is the number of Patients with a Positive (SARS-CoV-2) COVID-19 
Result Hospitalized with Access to the Intensive Care area with Intubation. 
Be: 
P + SARS-CoV-2 i j Hospital Intensive Care with Intubation = Positive (SARS-CoV-2) COVID-19 with 
Hospitalized modality and intubation in the State, Municipality. 
 
Definition 8.- P + SARS-CoV-2 i j Deaths.- Deaths of Patients with a positive result for SARS-CoV-2. Deaths 
are all those positive to (SARS-CoV-2) COVID-19 where one is indicated in the data record (DATE_DEF 
other than the value "99-99-9999"). 
 
Definition 9.- (SARS-CoV-2) COVID-19 case fatality rate.- It is the proportion of people who die from (SARS-
CoV-2) COVID-19 among the Patients with a positive (SARS-CoV-2) COVID-19 result in a given period and 
area. 
Be: 
TL SARS-CoV-2 i j = (SARS-CoV-2) COVID-19 case fatality rate 
Where: 
(SARS-CoV-2) COVID-19 case fatality rate = [(Deaths of Patients with a Positive (SARS-CoV-2) COVID-19 
Result in the State or Municipality) / (Total of Patients with a Positive (SARS-CoV-2) COVID-19 result in the 
State or Municipality)] x 100 
Of which: 
DP+ SARS-CoV-2 i j = Deaths of Patients with a positive (SARS-CoV-2) COVID-19 result in the State / 
Municipality 
And: 
P+ SARS-CoV-2 i j = Total Patients with a positive (SARS-CoV-2) COVID-19 result in the State / Municipality 
So: 
TL SARS-CoV-2 i j = [D P + SARS-CoV-2 i j / P + SARS-CoV-2 i j] x 100 
 
The data processing corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 1  June 2020. 
The treatment of the information is carried out through the application software for data mining Orange 
version 3.25.1, in which the algorithm for the information analysis are developed. (See Table 1 and Figure 
1, below). According to information from the Ministry of Health, the following records are available at the 
national level:   
1. The number of patients with a positive (SARS-CoV-2) COVID-19 result is 94,435 of which:  a) 60,828 
are Care Outpatients and b) 32,607 are Hospitalized patients. 
2. Of the 32,607 Hospitalized (SARS-CoV-2) COVID-19 Positive patients: a) 3,074 patients enter the 
Intensive Care Unit; while b) 29,499 patients do not enter the Intensive Care Unit. 
3. Only 1,712 Hospitalized (SARS-CoV-2) COVID-19 Positive patients admitted to the Intensive Care 
Unit required intubation; while 1,362 patients did not require intubation. 
4. Likewise, to date 10,167 deaths from positive (SARS-CoV-2) COVID-19 patients have been 
registered nationwide, of which 1,595 deaths corresponded to Positive (SARS-CoV-2) COVID-19 
 7 
patients who were in Intensive Care Intubation and 7,510 corresponded to (SARS-CoV-2) COVID-
19 Positive patients who were not in Intensive Care. 
5. The number of women with a positive (SARS-CoV-2) COVID-19 diagnosis is 40,693; while the 
number of men is 52,742.  This information is presented in the following table 1. 
 
Table 1. Total number of cases in Mexico as of June 1, 2020, 
According to Sex and Result at (SARS-CoV-2) COVID-1 
  
 Sex  
Result    Women          Men             Total  
Positive  (SARS-CoV-2) COVID-1  40,693   52,742   93,435   
No positive (SARS-CoV-2) COVID-1  78,702   71,455   150,157  
Pending result  18,572   19,925  38,497  
Total   137,967   144,122   282,089   
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases as of June 
1, 2020. 
 
Figure 1. Algorithm for the identification of patients  
(SARS-CoV-2) COVID 19 in Mexico in Orange Data Mining version 3.25.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Self made. With information provided by the Ministry of Health as of 1 June 2020 and 
Orange Data Mining version 3.25.1 
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